Quality of randomized controlled trials reporting in the treatment of sarcomas

Journal of Clinical Oncology

Volumn 29, Issue 9, 2011, Pages 1204-1209

  Toulmonde, Maud ^a   Bellera, Carine ^a   Mathoulin Pelissier, Simone ^a   Debled, Marc ^a   Bui, Binh ^a   Italiano, Antoine ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER THERAPY; METHODOLOGY; OSTEOSARCOMA; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOFT TISSUE SARCOMA;

ADULT; BONE NEOPLASMS; HUMANS; JOURNAL IMPACT FACTOR; MEDLINE; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SARCOMA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79952755177     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.30.9369     Document Type: Article

References (22)

1. Moher D, Pham B, Jones A, et al: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609-613, 1998
2. Begg C, Cho M, Eastwood S, et al: Improving the quality of reporting of randomized controlled trials: The CONSORT statement. JAMA 276:637-639, 1996 (Pubitemid 26278070)
3. Moher D, Jones A, Lepage L: Use of the CONSORT statement and quality of reports of randomized trials: A comparative before-and-after evaluation. JAMA 285:1992-1995, 2001
4. Altman DG, Schulz KF, Moher D, et al: The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 134:663-694, 2001 (Pubitemid 32322245)
5. Casali PG, Jost L, Sleijfer S, et al: Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20:132-136, 2009 (suppl 4)
6. Demetri GD, Baker LH, Beech D, et al: Soft tissue sarcoma clinical practice guidelines in oncology. J Natl Compr Canc Netw 3:158-194, 2005 (Pubitemid 44265447)
7. Lai R, Chu R, Fraumeni M, et al: Quality of randomized controlled trials reporting in the primary treatment of brain tumors. J Clin Oncol 24:1136-1144, 2006 (Pubitemid 46638811)
8. Rios LP, Odueyungbo A, Moitri MO, et al: Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab 93:3810-3816, 2008
9. Schulz KF, Chalmers I, Hayes RJ, et al: Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412, 1995
10. Huwiler-Muntener K, Juni P, Junker C, et al: Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 287:2801-2804, 2002 (Pubitemid 34591968)
11. Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions: Version 5.0.2. The Cochrane Collaboration, 2009, www.cochrane-handbook.org
12. Montori VM, Bhandari M, Devereaux PJ, et al: In the dark: The reporting of blinding status in randomized controlled trials. J Clin Epidemiol 55:787-790, 2002
13. Fleiss JL: Statistical methods for rates and proportions (ed 2). New York, NY, John Wiley, 1981, pp 38-46
14. Zeger SL, Liang KY, Albert PS: Models for longitudinal data: A generalized estimating equation approach. Biometrics 44:1049-1060, 1988 (Pubitemid 19026037)
15. Mathoulin-Pelissier S, Gourgou-Bourgade S, Bonnetain F, et al: Survival end point reporting in randomized cancer clinical trials: A review of major journals. J Clin Oncol 26:3721-3726, 2008
16. Plint AC, Moher D, Morrison A, et al: Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 185:263-267, 2006 (Pubitemid 44382877)
17. Devereaux PJ, Manns BJ, Ghali WA, et al: The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials 23:380-388, 2002
18. Boutron I, Tubach F, Giraudeau B, et al: Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. J Clin Epidemiol 57:543-550, 2004 (Pubitemid 38891491)
19. Kober T, Trelle S, Engert A: Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals. J Natl Cancer Inst 98:620-625, 2006
20. Sinha S, Ashby E, Jayaram R, et al: Quality of reporting in randomized trials published in high-quality surgical journals. J Am Coll Surg 209:565-571, 2009
21. Devereaux PJ, Choi PT, El-Dika S, et al: An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol 57:1232-1236, 2004 (Pubitemid 40023142)
22. Pildal J, Chan AW, Hrobjartsson A, et al: Comparison of descriptions of allocation concealment in trial protocols and the published reports: Cohort study. BMJ 330:1049, 2005